Creatine Kinase Reagent Market Size, Share, Trends, Growth 2032

Creatine Kinase Reagent Industry Prospective:

The global creatine kinase reagent market size was worth around USD 372.14 million in 2023 and is predicted to grow to around USD 914.04 million by 2032 with a compound annual growth rate (CAGR) of roughly 10.50% between 2024 and 2032.

Request Free Sample

Creatine Kinase Reagent Market: Overview

Creatine kinase reagent chemical solution is used for diagnosing and monitoring the activity of creatine kinase (CK) enzymes found in blood plasma and serum. A reagent is defined as a compound or substance that is added to an existing system to encourage a chemical reaction or to check if any such reaction occurs. In analytical chemistry, reagents are used for detecting the presence of another substance. In the case of creatine kinase reagent, it is used for determining the level of creatine kinase (CK) enzyme in blood plasma. It is found primarily in the brain or muscles. In case of an injury or muscle damage, the levels of CK enzyme in the body may rise. Medical professionals use creatine kinase reagents to detect muscle injury especially related to the heart. The presence of CK in a sample is an indication of the formation of creatine and adenosine triphosphate (ATP) which is converted from creatine phosphate and adenosine diphosphate (ADP). The quantity of ATP thus converted directly relates to the intensity of CK activity which in turn helps the medical professionals diagnose the existing problem. The use of creatine kinase reagents in medical diagnosis is expected to rise during the projection period. However, the industry will also face multiple challenges mainly due to the disruptions in the supply chain of materials needed to conduct the tests.

Key Insights:

• As per the analysis shared by our research analyst, the global creatine kinase reagent market is estimated to grow annually at a CAGR of around 10.50% over the forecast period (2024-2032)
• In terms of revenue, the global creatine kinase reagent market size was valued at around USD 372.14 million in 2023 and is projected to reach USD 914.04 million, by 2032.
• The market is projected to grow at a significant rate due to the rising number of patients with heart conditions
• Based on the application, the diagnostic use segment is growing at a high rate and will continue to dominate the global market as per industry projection
• Based on the end-user, the diagnostic laboratories segment is anticipated to command the largest market share
• Based on region, North America is projected to dominate the global market during the forecast period

Request Free Sample

Creatine Kinase Reagent Market: Growth Drivers

Rising number of patients with heart conditions will create more market demand

The global creatine kinase reagent market is expected to witness high growth due to the increasing number of patients with heart conditions or cardiovascular diseases (CVDs). Creatine kinase is an effective biomarker for cardiac conditions. Thus CK quantification is regularly used by medical professionals to detect the prevalence of critical and common heart conditions such as acute myocardial infarction, acute coronary syndrome, ischemia, and congestive heart failure. The rising number of patients with these diseases is expected to fuel the demand for creatine kinase reagents. As per the World Health Organization (WHO), cardiovascular diseases are the leading reasons of death across the globe. As per official estimates, the condition affects nearly 18 million people every year worldwide. Some of the main risk factors associated with CVDs include physical inactivity, diabetes, high blood pressure, high cholesterol, and obesity. In some cases, the condition is related to family background and ethnicity. The changing consumer lifestyle that includes excessive consumption of fatty food with high cholesterol levels along with a sedentary way of living is considered a major reason for the increasing prevalence of heart conditions among the current generation, including those below the age of 30 years. As per official statistics, more than 32,000 people in India died due to cardiac arrest in 2022.

Increasing global healthcare expenditure will fuel a higher market growth rate

The demand for creatine kinase reagents is expected to benefit from the increasing healthcare expenditure across the globe. The demand for affordable medical care is rising rapidly globally. World organizations and regional governments are under pressure to meet the rapidly increasing medical needs of the general population. Additionally, more efforts are being made toward providing access to quality medical attention among the underprivileged segments of the society thus helping the global creatine kinase reagent market grow. In May 2022, the Nigerian government announced that it would set up a new fund to cover over 83 million poor people in the region who are unable to afford health insurance premiums.

Creatine Kinase Reagent Market: Restraints

Disruptions in the supply chain of raw materials and final goods could restrict the market growth rate

The global industry for creating kinase reagents is expected to be restricted due to disruptions in the supply chain of final goods and the procurement of primary raw materials. Additionally, the industry is yet to find a larger consumer base in emerging economies since the solution is predominantly witnessed in regions with robust diagnostic infrastructure. The growing investments in developing diagnostic solutions and technology could impact the market growth rate during the projection period.

Creatine Kinase Reagent Market: Opportunities

Increasing investments in the construction and development of novel diagnostic centers will generate high-growth opportunities

The global creatine kinase reagent market is expected to generate new growth opportunities due to the increasing investments in the construction of new and advanced diagnostic centers. The regional healthcare infrastructure monitoring officials are investing in developing new centers while facilitating the addition of new technologies in existing centers. Additionally, diagnostic center companies are focusing on improving patient care by introducing new solutions under one roof for comprehensive care. For instance, in May 2021, India-based Neuberg Diagnostics announced the launch of its new diagnostic center in the US region. The ongoing research to seamlessly integrate modern technological solutions such as machine learning, cloud-based data-sharing platforms, and other technologies could also prove beneficial for the market in the long run. Researchers are working on learning to leverage machine learning (ML) technology to assess the results obtained using creatine kinase reagents for higher accuracy.

Rising demand for customized medical care will generate high growth opportunities for CK reagents

The demand for personalized medical care is steadily rising. Medical conditions affecting the world population are evolving and in most cases, a treatment effective for one patient may not provide the same results for other sets of patients. The changing medical needs of the patients are driving the need for developing customized medical solutions that could in turn open higher growth opportunities for the global creatine kinase reagent market.

Creatine Kinase Reagent Market: Challenges

High competition from other diagnostic solutions could challenge the market expansion rate

The global creatine kinase reagent market is expected to be challenged by the existence and adoption of alternative diagnostic solutions including the use of muscle imaging devices. In June 2023, the United Kingdom registered an investment of £85.9 million for the construction of three new imaging centers in the Norfolk and Waveney regions. The otherwise popular subsidies to CK reagents include genetic testing, exercise testing, and electromyography (EMG) all of which are witnessing substantial growth.

Creatine Kinase Reagent Market: Segmentation

The global creatine kinase reagent market is segmented based on application, product, end-user, and region.

Based on application, the global market segments are diagnosis use and research use. In 2023, the highest demand was witnessed in the diagnosis use segment due to the growing use of CK reagents in diagnosing cardiovascular diseases. The rising prevalence of heart-related conditions globally is the primary segmental growth factor. As per the Centers for Disease Control and Prevention (CDC), more than 800,000 people in the US have heart attacks every year. The research use applications can help in better understanding of muscle disorders and functioning.

Based on product, the global creatine kinase reagent industry is segmented into creating kinase kits, creatine kinase instruments, and creatine kinase reagents.

Based on end-users, the global market divisions are clinics, hospitals, academic research centers, and diagnostic laboratories. In 2023, the highest demand was observed in the diagnostic laboratories segment. The rising investments in diagnostic centers and technology will fuel the segment growth rate. Hospitals are expected to deliver significant results due to the growing patient footfall across hospitals worldwide. In 2023, the US healthcare industry was valued at over USD 900 billion.

Creatine Kinase Reagent Market Report Scope

Creatine Kinase Reagent Market: Regional Analysis

North America to witness the highest growth rate during the projection period

The global creatine kinase reagent market is expected to witness the highest growth in North America with the US leading the regional revenue. The increasing number of CVD patients in Canada and the US will stir the regional market growth rate. As per official data, 1 in every 20 Canadian citizens over the age of 20 years is currently living with a diagnosed heart condition while several others may be living with undiagnosed conditions. The regional market is fueled by access to preliminary healthcare and quick response to medical problems in terms of diagnosis and action. In March 2024, Canada registered an investment of over CAD 86 million in the healthcare system of the Yukon region. The rapidly rising investments in the development of new diagnostic solutions as well as improvements in the existing technologies will further promote the region’s growth rate. The US is registering a surging interest in AI diagnostic tools which may create more opportunities for the regional players. Furthermore, medical research in North America remains one of the world’s most sought-after sectors as the US dominates the global medical research market in terms of funds and engineered solutions.

Creatine Kinase Reagent Market: Competitive Analysis

The global creatine kinase reagent market is led by players like:

• Thermo Fisher Scientific
• Siemens Healthineers
• Wako Chemicals
• Beckman Coulter
• Mindray
• Tosoh Corporation
• Roche Diagnostics
• PerkinElmer
• Ortho Clinical Diagnostics
• Abcam
• Abbott Laboratories
• Sekisui Diagnostics
• Bio-Rad Laboratories
• HORIBA Medical
• Randox Laboratories

The global creatine kinase reagent market is segmented as follows:

By Application

• Diagnosis Use
• Research Use

 By Product

•  Creatine Kinase Kits
•  Creatine Kinase Instruments
•  Creatine Kinase Reagents

By End-User

• Clinics
• Hospitals
• Academic Research Centers
• Diagnostic Laboratories

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa